In this issue
The latest complimentary webinars, industry podcasts and articles, bioanalytical assays, and more!
Exploring microsampling applications, benefits, and considerations in preclinical, clinical, and bioanalytical research during early phase drug development. Includes two case studies!
Making Early Phase Drug Development More Efficient
Engaging with a single partner through the critical early stages can make all the difference.
Timely PK Analysis Supports Data-Driven Decisions
Exploring the benefits of including pharmacokinetic analysis between cohorts in first-in-human studies.
Keep up to date on the latest news from and about Altasciences.
View the latest on-demand webinars and catch up on some of our favorites, including a new presentation on navigating the abuse potential evaluation of CNS-active drugs for European and American submissions.
HListen to discussions about the principles of the 3Rs in preclinical studies, large molecule bioanalysis, Altasciences’ unique approach to scientific project management, and research support services.
- Up Close and Personal with…
Meet Dr. Gaetano Morelli, Chief Medical Officer at Altasciences.
Learn more about protocol design concepts in Phase I ethnobridging clinical trials.
LET'S STAY CONNECTED!
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.